PROSPECTO: INFORMATION FOR THE USER
Azitromicina Qualigen 200 mg/5 ml powder for oral suspension EFG
Read this prospect carefully before starting to take this medicine, because it contains important information for you
Azitromicina belongs to a group of antibiotics called macrolides.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold. It is essential to follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor. Do not store or reuse this medication. If you have leftover antibiotics after treatment, return them to the pharmacy for proper disposal. Do not dispose of medications through the drain or in the trash. |
It is used to treat bacterial infections caused by microorganisms such as bacteria. These infections include:
Do not take Azitromicina Qualigen:
Warnings and precautions
Consult your doctor before starting to take Azitromicina Qualigen if you:
If you experience severe and persistent diarrhea, especially with blood or mucus, during or after treatment, consult your doctor immediately.
If symptoms persist after completing treatment with azithromycin or if you notice any new and persistent symptoms, inform your doctor.
Children and adolescents
This medication is not indicated for children under 1 year of age.
For the treatment of sinusitis, available data in children under 16 years are limited (see section 3).
Use of Azitromicina Qualigen with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
No interactions have been observed between azithromycin and cetirizine (an antihistamine); didanosine, efavirenz, indinavir (for HIV infection); atorvastatin (for cholesterol and heart problems); carbamazepine (for epilepsy), cimetidine (an antacid); methylprednisolone (to suppress the immune system); midazolam, triazolam (sedatives); sildenafil (for impotence), theophylline (for asthma) and trimethoprim/sulfamethoxazole (a combination antibiotic).
Use of Azitromicina Qualigen with food and drinks
The oral suspension can be taken with or without food and drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.
There is not enough information about the use of azithromycin during pregnancy. Therefore, azithromycin is not recommended if you are pregnant or plan to become pregnant. However, your doctor may prescribe it in serious cases.
Azithromycin is not recommended during breastfeeding as it may cause side effects such as diarrhea and infection in the baby. You can continue breastfeeding two days after completing treatment with Azitromicina Qualigen.
Driving and operating machinery
There is no evidence that Azitromicina Qualigen affects the ability to drive or operate machinery.
Azitromicina Qualigen contains saccharose and glucose
This medication contains saccharose and glucose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
Patients with diabetes mellitus should note that this medication contains 3.869 g of saccharose per 5 ml of reconstituted suspension.
This medication contains less than 23 mg of sodium (1 mmol) per 12.5 ml of reconstituted suspension; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
This medication is administered orally. To facilitate administration, each bottle is accompanied by a dosing syringe.
This medication is not indicated for children under 1 year of age, see the sectionChildren and Adolescents.
Dose
The azithromycin suspension should be administered in a single dose once a day, with or without food.
Shake the bottle vigorously before using the suspension.
There are other presentations available for different dosing regimens. The usual dose is as follows:
Use in children and adolescents over 45 kg of weight, adults, and elderly people
The total dose of azithromycin is 37.5ml (1,500 mg) administered over 3 days (12.5 ml (500 mg) once a day). Alternatively, the dose can be administered over 5 days (12.5 ml (500 mg) as a single dose on the first day and continue with 6.25 ml (250 mg) once a day).
For urethritis or cervicitis caused byChlamydia, the dose is 25 ml (1,000 mg) as a single dose.
The treatment of sinusitis is only indicated for adults and adolescents over 16 years of age.
There are other presentations available that are more suitable for patients with a weight over 45 kg.
Use in children and adolescents under 45 kg of weight
The treatment with azithromycin suspension should be measured carefully, with the help of the dosing syringe that comes with it, according to the child's weight, according to the following table:
Weight | 3-day treatment | 5-day treatment |
10-15 kg | 0.25 ml/kg (10 mg/kg) once a day, from day 1 to 3 | 0.25 ml/kg (10 mg/kg) as a single dose on the first day, followed by 0.125 ml (5 mg/kg) once a day, from day 2 to 5 |
16-25 kg | 5 ml (200 mg) once a day, from day 1 to 3 | 5 ml (200 mg) as a single dose on the first day, followed by 2.5 ml (100 mg) once a day, from day 2 to 5 |
26-35 kg | 7.5 ml (300 mg) once a day, from day 1 to 3 | 7.5 ml (300 mg) as a single dose on the first day, followed by 3.75 ml (150 mg) once a day, from day 2 to 5 |
35-45 kg | 10 ml (400 mg) once a day, from day 1 to 3 | 10 ml (400 mg) as a single dose on the first day, followed by 5 ml (200 mg) once a day, from day 2 to 5 |
>45 kg | The same dose as for adults |
For the treatment of pharyngitis/tonsillitis in children 2 years of age or older: the recommended dose of azithromycin is a single dose of 10 mg/kg or 20 mg/kg over 3 days, in which a maximum daily dose of 500 mg should not be exceeded.
Sinusitis
For the treatment of sinusitis, the available data in children under 16 years of age are limited.
Patients with liver or kidney problems:
Inform your doctor if you have liver or kidney problems as you may need to modify the usual dose.
Preparation of the suspension
1. Preparation of the suspension
Each 5 ml of reconstituted suspension will contain 200 mg of Azithromycin.
The oral suspension, reconstituted can be kept at room temperature for a period of 10 days; after this time, the remaining solution should be discarded.
The powder for suspension can exceed the level marked on the bottle, due to the specific density of the preparation.
2. Administration of the dose
The dosing syringe is also graduated to be able to administer the dose according to the child's weight.
Once the syringe is prepared, administer immediately.
WARNING: ADMINISTER THE MEDICINE SLOWLY TO THE CHILD AND ENSURE IT IS INCORPORATED. IN THIS WAY, YOU WILL AVOID THE RISK OF ASPHYXIATION.
If you take more Azithromycin Qualigen than you should
If you (or someone) take more azithromycin than you should, inform your doctor or pharmacist immediately. A overdose is likely to cause temporary hearing loss, intense nausea, vomiting, and diarrhea.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20.
If you forget to take Azithromycin Qualigen
Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Azithromycin Qualigen
Do not stop taking your medication without consulting your doctor, even if you feel better. It is very important that you continue to take Azithromycin Qualigen for the time your doctor has indicated, if not, the infection could reappear.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following, stop taking the tablets and seek immediate medical attention or go to the nearest hospital emergency department.
These are serious but rare side effects. You may need urgent medical attention or hospitalization.
The following side effects have been reported:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from available data):
The following side effects have been reported in patients treated with azithromycin for the prevention of Mycobacterium Avium Complex (MAC) infections:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Reporting of side effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish Medicines for Human Use Pharmacovigilance System Website: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Sealed vials: No special storage conditions are required. Store in the original packaging.
Reconstituted solution: 10 days.Record the date of reconstitution in the designated box on both the box and the vial label. Do not take the medication after 10 days of reconstitution; discard any remaining solution.
Keep this medication out of the sight and reach of children.
Do not use Azitromicina Qualigen after the expiration date indicated on the packaging after CAD.
The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the containers and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused containers and medications. By doing so, you will help protect the environment.
Composition of Azitromicina Qualigen 200 mg / 5 ml powder for oral suspension
Appearance of the product and contents of the packaging
This medicine is an almost white powder for oral suspension with a banana-strawberry odor. It is packaged in amber type III glass bottles, closed with a polyethylene cap with a polyethylene stopper.
Each carton box contains a 15 ml or 30 ml bottle.
A polypropylene/polietilene dosing syringe with a polyethylene stopper is included.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
Responsible for manufacturing
Neuraxpharm Pharmaceuticals, S.L.
Avda. de Barcelona, 69.
08970 Sant Joan Despí – Barcelona
Spain
This leaflet was approved in April 2023
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.gob.aemps
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.